An open-label, 3 doses fixed sequence trial investigating safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral and intravenous administrations of FE 201836 in elderly subjects
Active, not recruitingNL-OMON43334
Ferring Pharmaceuticals A/SNocturia
Excessive night-time urination
Start: 2016-11-09Target: 24Updated: 2024-02-28